| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.007 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |